MPT Product Development Database

This database includes MPT products that are currently available, as well as MPT products in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Click here to learn more about the inclusion criteria and information update methodology.
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!
Click on the table for MPT products in the development pipeline by indication combination.
Product TypeDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

31 product(s) found

Results: 9 product(s) found
BioRings TM IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Ascorbic Acid
  • Boc-Lysinated Betulonic Acid
  • Ferrous Gluconate
  • Polyamino-Polycarboxlic Acid
  • Tenofovir (TFV)
  • BioRings LLC
  • P1
  • HIV
  • Pregnancy
  • Dapivirine + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • International Partnership for Microbicides (IPM)
  • C1
  • HIV
  • Pregnancy
  • Griffithsin (GRFT) IVR (PC-7500) MPT in Development Topical Intravaginal Ring (IVR)
  • Griffithsin (GRFT)
  • Population Council
  • P1
  • HIV
  • HPV
  • HSV-2
  • mAb 2C7 + TDF IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • MassBiologics
  • Oak Institute of Science
  • Planet Biotechnology, Inc.
  • University of Massachusetts
  • P1
  • Gonorrhea
  • HIV
  • Tenofovir / Acyclovir IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Tenofovir (TFV)
  • CONRAD
  • P2
  • HIV
  • HSV-1
  • HSV-2
  • Tenofovir + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Levonorgestrel
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir Disoproxil Fumarate (TDF) IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Albert Einstein College of Medicine
  • C1
  • HIV
  • HSV-2
  • Tenofovir IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • TFV + Acyclovir + Ethinyl Estradiol + Etonogestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Ethinyl Estradiol
  • Tenofovir (TFV)
  • Auritec Pharmaceuticals
  • Oak Institute of Science
  • P2
  • HIV
  • HSV-2
  • Pregnancy
  • IMPT Secretariat
    308 Natoma Street, Suite 150
    Folsom, CA 95630
    +1.916.932.4785 | This email address is being protected from spambots. You need JavaScript enabled to view it.

    © Copyright 2018, IMPT Secretariat. All rights reserved.

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to advancing the comprehensive sexual and reproductive health of women and girls worldwide. CAMI Health is housed at the Public Health Institute (PHI).

    This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.
    CAMI Health PHI USAID PEPFAR